Atorvastatin
(Redirected from Atorvastatin clinical studies)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Atorvastatin calcium (Lipitor)
Amlodipine besylate/Atorvastatin calcium
Amlodipine/Atorvastatin
Ezetimibe/Atorvastatin
Overview
Atorvastatin is a HMG-COA Reductase Inhibitor drug that is FDA approved for the treatment of hyperlipidemia, prevention of cardiovascular disease. Adverse reactions include diarrhea, arthralgia, myalgia, urinary tract infectious disease, nasopharyngitis, pain, in extremity.
Category
HMG-COA Reductase Inhibitor